GlassScriptPhysician profile
Ami Hiatt Keatts
NPI 1639260391
$7,183.71
in general payments reported to CMS, 2019-2025
21 companies · $4,584 in 2025
The $4,584 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $49.34 · 2021: $15.16 · 2022: $1,322 · 2023: $106 · 2024: $861 · 2025: $4,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,545 · Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,545.36 |
| Food and Beverage | $1,005.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,101.68 | 2024-2025 | |
| Applied Medical Resources Corporation | $1,166.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.65 | 2019-2025 | |
| Abbvie INC. | $133.54 | 2019-2023 | |
| Astellas Pharma US INC | $98.61 | 2019-2025 | Veozah |
| Biogen, INC. | $94.98 | 2024-2025 | Zurzuvae |
| Organon LLC | $83.39 | 2022-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $72.48 | 2019-2025 | Gardasil 9 |
| Exact Sciences Corporation | $38.22 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $33.00 | 2019 | |
| Pfizer INC. | $26.40 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $26.36 | 2019 | |
| Coopersurgical, INC. | $23.90 | 2022 | |
| Myovant Sciences INC. | $17.68 | 2022 | |
| Sumitomo Pharma America, INC. | $16.38 | 2023 | Myfembree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.89 | 2019 | |
| Minerva Surgical, INC | $14.70 | 2020 | |
| Amgen INC. | $14.14 | 2022 | |
| Novo Nordisk INC | $13.72 | 2025 | Wegovy |
| Lilly USA, LLC | $13.60 | 2025 | Mounjaro, Zepbound |
| Therapeuticsmd, INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Keatts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.